EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rational design of pyrazole–oxime hybrids as dual-targeting agents for glioma and breast cancer brain metastasis

Merve Gul, Mehmet Abdullah Alagoz, Ceylan Hepokur, Oztekin Algul

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05618-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Merve Gul und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Inonu University, Malatya, Türkiye. Hauptthemen laut MEDLINE: Oximes, Pyrazoles, Drug Design, Brain Neoplasms. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inönü Üniversitesi, Inonu University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To design, synthesize, and biologically evaluate a novel series of 1-(4-chlorophenyl)-2-(4-methylpyrazol-1-yl)ethenone oxime derivatives ( 5–15 ) as targeted anticancer agents, focusing on their selectivity for glioma, mechanistic action, and blood–brain barrier (BBB) permeability. The oxime derivatives were synthesized and characterized using 1 H-NMR, 13 C-NMR, and mass spectrometry. In vitro cytotoxicity was assessed against C6 (glioma), MCF-7 (breast cancer), and SH-SY5Y (human neuroblastoma) cell lines. Flow cytometry evaluated apoptosis and cell cycle arrest for the lead compound. Molecular docking simulations were performed against CDK6 (PDB: 5L2I) and P-glycoprotein/ABCB1 (PDB: 7A6E). All derivatives exhibited selective potency against C6 glioma cells. Compound 14 demonstrated the highest antiproliferative activity (IC₅₀: 31.23 µM) against tumor lines while sparing SH-SY5Y cells. Flow cytometry confirmed that compound 14 triggers apoptosis and induces cell cycle arrest in C6 cells. Molecular docking predicted the most favorable docking scores for compound 14 against both CDK6 and P-glycoprotein. Structure–activity relationships (SAR) analysis validates the 4-methylpyrazole core as a viable scaffold for targeted glioma therapy. These results suggest that further functionalization of the O-alkyl oxime moiety merits further investigation as a starting point for potentially brain-penetrant scaffolds, although in vivo and target-level validation are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OximesPyrazolesDrug DesignBrain NeoplasmsBreast NeoplasmsAntineoplastic AgentsGliomaHumansMolecular Docking SimulationFemaleApoptosisAnimalsCell Line, TumorStructure-Activity RelationshipCyclin-Dependent Kinase 6RatsBlood-Brain BarrierMCF-7 CellsCell ProliferationCell Cycle CheckpointsATP Binding Cassette Transporter, Subfamily B, Member 1

Stichwörter der Autor:innen

ApoptosisBreast cancerCDK6Pyrazole derivativesSAR

Substanzen

OximesPyrazolesAntineoplastic AgentsCyclin-Dependent Kinase 6CDK6 protein, humanATP Binding Cassette Transporter, Subfamily B, Member 1

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Inonu University, Malatya, Türkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Inonu University, Malatya, Türkiye. mehmet.alagoz@inonu.edu.tr.
  • Department of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Türkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mersin University, Mersin, Türkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, Erzincan, Türkiye.

Förderung

  • Inönü Üniversitesi
  • Inonu University

Zitieren

APA

Gul, M., Alagoz, M. A., Hepokur, C., & Algul, O. (2026). Rational design of pyrazole–oxime hybrids as dual-targeting agents for glioma and breast cancer brain metastasis. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05618-w

Vancouver

Gul M, Alagoz MA, Hepokur C, Algul O. Rational design of pyrazole–oxime hybrids as dual-targeting agents for glioma and breast cancer brain metastasis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05618-w

BibTeX
@article{Gul2026,
  author = {Gul, Merve and Alagoz, Mehmet Abdullah and Hepokur, Ceylan and Algul, Oztekin},
  title = {Rational design of pyrazole–oxime hybrids as dual-targeting agents for glioma and breast cancer brain metastasis},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05618-w}
}
Kostenlos starten →